Literature DB >> 17951204

Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma.

Megan Q Zhang1, Fan Lin, Pei Hui, Zong-Ming E Chen, Jon H Ritter, Hanlin L Wang.   

Abstract

Expression of gastrointestinal biomarkers MUC1, MUC2, MUC5AC, small-intestinal mucin antigen (SIMA), villin, and CDX2 has been studied in colorectal adenocarcinoma (CRC). Little is known, however, about their expression in small-intestinal adenocarcinoma (SIA). We immunohistochemically compared 30 SIAs with 48 CRCs for the expression of these biomarkers. The results showed that all 6 proteins were variably expressed in SIA, but the frequencies of expression were significantly lower than those for CRC with the exception of MUC1. Specifically, positive staining for MUC1, MUC2, MUC5AC, SIMA, villin, and CDX2 was observed in 16 (53%), 17 (57%), 12 (40%), 15 (50%), 20 (67%), and 18 (60%) of SIAs and 25 (52%), 43 (90%), 39 (81%), 45 (94%), 47 (98%), and 47 (98%) of CRCs, respectively. In addition, SIAs more frequently exhibited a focal staining pattern for MUC2, MUC5AC, SIMA, and villin, whereas more diffuse immunoreactivity was evident in CRCs. Focal staining for MUC1 and diffuse staining for CDX2 were common for SIAs and CRCs. Furthermore, poorly differentiated SIAs tended to express MUC1 more frequently when compared with well- and moderately differentiated SIAs. These observations further support the notion that SIA is immunophenotypically distinct from CRC despite their morphologic similarity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17951204     DOI: 10.1309/JAF3KVGJHQCJ1QF9

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  CDX2 as a marker for intestinal differentiation: Its utility and limitations.

Authors:  Reda S Saad; Zeina Ghorab; Mahmoud A Khalifa; Mei Xu
Journal:  World J Gastrointest Surg       Date:  2011-11-27

Review 2.  [Secondary tumors of the gastrointestinal tract].

Authors:  C Langner
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

3.  Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Authors:  Vera N Senchenko; Natalia P Kisseljova; Tatyana A Ivanova; Alexey A Dmitriev; George S Krasnov; Anna V Kudryavtseva; Grigory V Panasenko; Evgeny B Tsitrin; Michael I Lerman; Fyodor L Kisseljov; Vladimir I Kashuba; Eugene R Zabarovsky
Journal:  Epigenetics       Date:  2013-03-11       Impact factor: 4.528

4.  Immunophenotype and molecular characterisation of adenocarcinoma of the small intestine.

Authors:  M J Overman; J Pozadzides; S Kopetz; S Wen; J L Abbruzzese; R A Wolff; H Wang
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

5.  Differential binding of IgG and IgA to mucus of the female reproductive tract.

Authors:  Kelly M Fahrbach; Olga Malykhina; Daniel J Stieh; Thomas J Hope
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

6.  Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer.

Authors:  Hiroaki Shibahara; Michiyo Higashi; Chihaya Koriyama; Seiya Yokoyama; Iwao Kitazono; Yasuhiro Kurumiya; Michihiko Narita; Shingo Kuze; Takanori Kyokane; Saburo Mita; Toshiyuki Arai; Takehito Kato; Norihiro Yuasa; Ryuzo Yamaguchi; Hitoshi Kubota; Hideaki Suzuki; Satoshi Baba; Karine Rousseau; Surinder K Batra; Suguru Yonezawa
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

7.  Metastatic colon cancer of the small intestine diagnosed using genetic analysis: a case report.

Authors:  Mikiko Matsuo; Yuichiro Hatano; Yuko Imaizumi; Takahiro Kuroda; Toshinori Arai; Hiroyuki Tomita; Nobuhisa Matsuhashi; Kazuhiro Yoshida; Akira Hara
Journal:  Diagn Pathol       Date:  2020-08-31       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.